Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Oxytocin (5mg Vial) Dosage Chart - Peptide Dosages

Oxytocin (5mg Vial) Dosage Protocol Nonapeptide hormone (oxytocin-receptor agonist) — FDA-approved for obstetric use; social/wellness uses are research-only. Mix & measure Oxytocin · 5 mg Pre-filled with this protocol’s recommended BAC water and documented sta

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Oxytocin (5mg Vial) Dosage Protocol

Nonapeptide hormone (oxytocin-receptor agonist) — FDA-approved for obstetric use; social/wellness uses are research-only.

Mix & measure Oxytocin · 5 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Reconstitute: Add 3.0 mL bacteriostatic water to one 5 mg vial → final concentration ~1.67 mg/mL (1,667 mcg/mL; ~833 IU/mL).

Typical daily range: 100–500 mcg once daily, raised gradually over an 8–12 week research course.

Easy measuring: At ~1.67 mg/mL, 1 unit ≈ 16.7 mcg on a U-100 syringe (~1 IU ≈ 2 mcg). The 3.0 mL dilution keeps the starting 100 mcg dose at a readable 6 units.

Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Amycretin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Amycretin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
02IGF-1 DES — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 1 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 1 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. IGF-1 DES is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
03Retinalamin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Retinalamin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
04AHK-Cu — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 50 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 50 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. AHK-Cu is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
05Davunetide — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Davunetide is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
Research context

Read sources and limitations before applying a claim.

What We Still Do Not Know: The Real Evidence Gaps

An honest inventory of open questions is more useful than a list of hopeful claims, so here is where the actual gaps lie — the places where a researcher can say precisely what is missing. The overarching problem is that Sermorelin’s own high-quality clinical evidence base is concentrated in the pediatric-diagnostic and pediatric-deficiency setting for which it was approved, and much of the modern enthusiasm rests on extrapolation from that setting, from adjacent stabilized analogs, or from mechanism alone.3 The table below separates what is reasonably established from what remains hypothesis. Pituitary stimulation Sermorelin reliably provokes endogenous GH release via GHRHR3 Durability and clinical meaning of chronic stimulation in non-deficient adults Diagnosis of GHD Validated as a provocative test (incl. GHRH-arginine)9 Whether/how to restore standardized GHRH-based testing to practice7 Somatopause / aging GH/IGF-1 decline with age is real and measurable8 Whether restoring the axis helps or harms over years8 Cognition A GHRH analog (tesamorelin) improved executive function in a trial5 Whether Sermorelin specifically reproduces this effect5 Body composition Stabilized GHRH analog reduces visceral fat in a defined disease10 Whether Sermorelin changes body composition meaningfully in healthy adults Long-term safety Short-term tolerability appears acceptable in studied settings4 Multi-year safety, especially any oncologic signal from raised IGF-1 Several of these gaps deserve emphasis because they are routinely papered over. The healthy-adult body-composition question is largely unstudied for Sermorelin itself; the visceral-fat data belong to tesamorelin in a specific disease population, and importing them is precisely the analog-substitution error.10 The long-term safety question is not hypothetical hand-wringing: IGF-1 is a mitogen, epidemiology links higher IGF-1 to certain cancer risks, and any intervention that chronically raises IGF-1 in older adults carries a theoretical oncologic concern that short trials cannot exclude. That the Baker trial kept IGF-1 “within the physiological range” is reassuring for that protocol but does not settle the matter for uncontrolled, indefinite off-label use.5 And the durability question follows directly from the pharmacology: a compound cleared in minutes, dosed to nudge nightly pulses, has no established multi-year outcome data in the wellness populations now using it. It is worth being blunt about the shape of the literature itself, because the type of evidence matters as much as its quantity. The frequently cited case for adult Sermorelin rests substantially on a two-page 2006 commentary framing it as “a better approach” to adult-onset GH insufficiency — a thoughtful argument from mechanism and clinical reasoning, but explicitly a hypothesis-generating perspective piece, not a randomized controlled trial reporting hard endpoints.4 There is, to date, no large, modern, placebo-controlled outcome trial of Sermorelin itself in healthy or aging adults that measures function, body composition, cognition, or safety over years and clears contemporary methodological standards. What exists instead is a scaffold assembled from three weaker supports: the robust but pediatric-diagnostic dataset for which the drug was approved,3 the well-run trials of other GHRH analogs such as tesamorelin,510 and the biologically reasonable but unproven inference that the same axis stimulation will translate into benefit. Recognizing that structure is not cynicism; it is simply reading the evidence at the level of rigor it actually occupies rather than the level its marketing implies. The methodological bottom line is that Sermorelin’s evidence architecture was built to answer a pediatric-diagnostic question and answered it well. It was not built to answer the adult anti-aging, body-composition, or cognition questions now asked of it, and those answers cannot be manufactured by borrowing from tesamorelin or from mechanism. For a grounded look at what the primary literature does and does not say about the compound’s core action, the site’s overview of what research says about Sermorelin’s role in stimulating natural growth hormone stays close to the demonstrated pharmacology.

Source: dosagepeptide.com ↗

Why EPO draws research interest

These are the directions researchers and the peptide community most often explore EPO for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to convert mcg to mg (and back)

Because the factor is exactly 1000, every conversion is a decimal-point move of three places — no calculator strictly required once you see the pattern: mcg → mg: divide by 1000, i.e. move the decimal point three places to the left. 500 mcg → 0.5 mg; 100 mcg → 0.1 mg; 1500 mcg → 1.5 mg. mg → mcg: multiply by 1000, i.e. move the decimal point three places to the right. 0.5 mg → 500 mcg; 2 mg → 2000 mcg; 1.25 mg → 1250 mcg. The tool above does the same move for you and trims trailing zeros, so you can paste in any value — whole or fractional — and read the exact counterpart.

Source: dosagepeptide.com ↗
Dosage reference

Glutathione (600mg Vial) Dosage Protocol

Master antioxidant tripeptide (GSH) — injectable use is not FDA-approved; presented for research and educational use. Concerned about side effects? See Glutathione side effects — what the research documents (honest, sourced, research-use-only). Looking for results? See Glutathione before and after — what the research actually shows (honest, research-based, no transformation photos).

Source: dosagepeptide.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →